Endovascular repair has become the standard of care for treatment of abdominal aortic aneurysms. The endografts and delivery systems for endovascular aneurysm repair have undergone multiple generations of technologic advancements. However, a significant remaining challenge for a satisfactory long-term outcome is to improve the performance of these devices in nonideal proximal sealing zones. In particular, short (<15 mm) and highly angulated (>60 degrees) necks can threaten long-term exclusion of the aneurysm even with the current generation of endografts. One of the main reasons for proximal infrarenal neck failure is the inability to accurately position the endograft precisely below both renal arteries.
The endografts and delivery systems for endovascular repair of abdominal aortic aneurysms (AAAs) have undergone multiple generations of technologic advancements. One of the few remaining challenges that prevents ubiquitous use of this technology is an unfavorable infrarenal aortic neck anatomy. 1, 2 In particular, short (<15 mm), highly angulated (>60 degrees) necks can threaten long-term exclusion of the aortic aneurysm, even with the current generation of endografts. However, with the integration of active control technology, namely, enhanced device positioning, conformability, and angulation control, the boundaries of treating an aneurysm with a "hostile" neck are continually being pushed. 3 Most current AAA endografts were designed for use in a relatively straight, uniform proximal neck. In a highly angulated neck, complete wall apposition is often unattainable with many current devices simply because the device cannot be delivered to conform to this hostile region. Most current devices are approved for relatively low-angled necks (#60 degrees), with only a small fraction of the devices Food and Drug Administration approved for an aortic neck angle up to 90 degrees. 1 Highly angulated necks may translate to potentially high rates of type I endoleaks and secondary interventions.
Current management of these highly angulated necks includes additional ballooning, proximal cuffs, balloonexpandable stents, endoanchors, chimney or snorkels, and use of complex fenestrated or branched endografts. Whereas many of these techniques involve off-label use of devices, none of these techniques is optimal, and all have individual challenges.
The next generation of endovascular endografts to specifically address these issues should ideally be engineered with the capability of actively angulating and "conforming" the proximal end of the graft to the native aortic anatomy before final deployment. This provides the physician with the ability to align the leading edge of the graft perpendicular to the flow lumen, thereby taking advantage of every millimeter of the available proximal sealing zone. With accurate orthogonal placement, wall apposition is maximized and sealing zone extended to the level of the renal arteries bilaterally.
This report presents the first-in-human experiences of the new investigational device, GORE EXCLUDER available in Europe. The clinical study will assess the safety and effectiveness of the device in treating infrarenal AAA in patients with challenging proximal aortic anatomy. The clinical study consists of two substudies, each assessing the device for a different range of patient anatomies. This first implantation was part of the short neck substudy to assess the device in aortic neck angles #60 degrees and aortic neck lengths $10 mm. The high neck angulation substudy will evaluate proximal aortic neck angles >60 degrees and #90 degrees and aortic neck lengths $10 mm. This report describes selected case experiences from 5 of the first 10 patients, all from different study sites and selected to highlight variation in anatomies treated, implanted in the investigational device exemption study. The Institutional Review Board at each participating institution approved the study protocol and the informed consent form. All patients gave written informed consent to participate in the study. 
